ACE2 and COVID-19: Nevertheless, there is evidence that Metformin could alter the expression and stability of ACE-2, a target of SARS-CoV-2 (25, 26), while also reducing tumor necrosis factor alpha (TNF-α) (27, 28), a proinflammatory cytokine involved in the prognosis of COVID-19 (29).